EFFECT OF HOMOEOPATHIC REMEDY ALLIUM SATIVUM IN REDUCING HBA1C IN TYPE2 DIABETES

A RANDOMISED PLACEBO CONTROLLED CLINICAL TRAIL TO DETERMINE THE EFFICACY OF POTENTIZED ALLIUM SATIVUM AS AN ADJUVANT TO MODERN MEDICINE IN REDUCING GLYCOSYLATED HAEMOGLOBIN IN TYPE2 DIABETES

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2022/10/046569

Enrollment

Registered

2022-10-18

Start date

Unknown

Completion date

Unknown

Last updated

2022-11-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E119- Type 2 diabetes mellitus without complications

Interventions

Intervention1: Homoeopathic Medicines: Individualized homoeopathic medicines prescribed according to homoeopathic principles. Potency and repetition of medicine can be changed in the follow ups, accor

Eligibility

Inclusion criteria

Inclusion criteria: Patients between 20-70 years of age, Patients already diagnosed with Type 2 diabetes with increased HbA1c,Patients of diabetes on Oral Antidiabetic Drugs,HbA1c levels >6.5%

Exclusion criteria

Exclusion criteria: Patient with diabetic nephropathy, Cases with Malignant Hypertension, Cases with diabetic foot ulcer, trophic ulcer, Gangrene & cellulitis, Pregnant women and lactating mothers, Known underlying Immunodeficiency deficiencies/serious illness (TB, cancer, AIDS)

Design outcomes

Primary

Measure	Time frame
To find out the action of potentized Allium sativum in reducing HbA1c in Type 2 DiabetesTimepoint: 12 months (6 months - enrolment and 6 months - intervention period) .	—

Secondary

Measure	Time frame
To measures the changes in FBS and PPBS after the administration of potentized Allium sativum.Timepoint: 12 months (6 months - enrolment and 6 months - intervention period) .	—

Countries

India

Contacts

Public ContactDR S G S CHAKRAVARTHY

National Homoeopathy Research Institute in Mental Health

sgschakravarthy@gmail.com9908019739

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026